In the BioHarmony Drug Report Database
Zaleplon
Sonata (zaleplon) is a small molecule pharmaceutical. Zaleplon was first approved as Sonata on 1999-08-13. It is used to treat sleep initiation and maintenance disorders in the USA.
Trade Name
|
Sonata |
|---|---|
Common Name
|
zaleplon |
ChEMBL ID
|
CHEMBL1521 |
Indication
|
sleep initiation and maintenance disorders |
Drug Class
|
Non-benzodiazepine anxiolytics, sedatives, hypnotics |
Image (chem structure or protein)